PHONE
+44-7482-878921
+44-7482-878921
2376-0249
Clinical-Medical Image - International Journal of Clinical & Medical Images (2024) Volume 11, Issue 6
Author(s): Hong Zheng*
Department of Internal Medicine, Aiginition University Hospital, 11528 Athens, Greece
Received: 01 June, 2024, Manuscript No. ijcmi-24-142586; Editor assigned: 03 June, 2024, Pre QC No. P-142586; Reviewed: 15 June, 2024, QC No. Q-142586; Revised: 22 June, 2024, Manuscript No. R-142586; Published: 29 June, 2024, DOI:10.4172/2376-0249.1000962
Citation: Zheng H. (2024) Integration of Imaging and Pathology in Cancer Diagnosis: A Case Study. Int J Clin Med Imaging 11: 962.
Copyright: © 2024 Zheng H. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
The integration of imaging and pathology has revolutionized cancer diagnosis and treatment planning, offering clinicians a comprehensive view of disease progression at both macroscopic and microscopic levels. This manuscript explores the synergistic relationship between imaging modalities such as MRI, CT, and PET scans, and pathological analysis through biopsies and histopathology. Using a case study approach, this paper illustrates how combining these diagnostic techniques enhances accuracy in identifying cancerous tissues, determining tumor characteristics, and guiding therapeutic decisions. The integration of imaging and pathology not only improves diagnostic precision but also facilitates personalized treatment strategies tailored to individual patient needs, thereby advancing the field of oncology. The integration of imaging and pathology represents a pivotal advancement in the field of oncology, offering clinician’s unprecedented insights into cancer diagnosis and treatment. Imaging modalities such as Magnetic Resonance Imaging (MRI), Computed Tomography (CT), and Positron Emission Tomography (PET) scans provide detailed anatomical and functional information about tumors [1].
In clinical practice, the synergy between imaging and pathology is exemplified by their collaborative roles in elucidating tumor characteristics. Consider a case where a patient presents with a suspicious lesion detected on a routine mammogram. The initial imaging study, typically a mammogram or breast MRI, highlights the location and size of the abnormality. Following this, a core needle biopsy is performed to obtain tissue samples for pathological analysis. Histopathological examination of these samples reveals cellular morphology, proliferation rate, and expression of specific biomarkers such as Estrogen Receptors (ER), Progesterone Receptors (PR), and Human Epidermal Growth Factor Receptor 2 (HER2/neu). Furthermore, advancements in imaging technology, such as functional MRI and molecular imaging probes, continue to enhance the integration of imaging and pathology in cancer diagnosis. Functional MRI techniques like diffusion-weighted imaging (DWI) and perfusion imaging offer insights into tissue microstructure and blood flow characteristics, which are valuable for assessing tumor aggressiveness and treatment response. Molecular imaging probes, such as radiolabeled tracers used in PET scans, enable non-invasive visualization of specific molecular targets or metabolic pathways implicated in cancer biology [2].
Cancer diagnosis; Pathology; Case study
None.
[1] Seyedian SS, Nokhostin F and Malamir MD. (2019). A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease. J Med Life 12(2): 113.
Google Scholar, Crossref, Indexed at
[2] Wang R, Li Z, Liu S and Zhang D. (2023). Global, regional and national burden of inflammatory bowel disease in 204 countries and territories from 1990 to 2019: A systematic analysis based on the Global Burden of Disease Study 2019. BMJ Open 13(3): e065186.
Awards Nomination
